跳至主要内容
临床试验/NCT07135037
NCT07135037招募中2 期

Efficacy of L- Arginine Versus Sildenafil in Management of Idiopathic Oligohydramnios

Kafrelsheikh University2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2024年9月1日最近更新:
干预措施
相关药物

试验速览

阶段
2 期
状态
招募中
入组人数
40
试验地点
2
主要终点
Improvement of amniotic fluid index

研究概览

简要总结

Based on previous studies, Both sildenafil and L-arginine helped to improve idiopathic oligohydramnios.

In this study, Level of improvment of oligohydramnios will be compared. As well as, NICU admission to neonates of pregnancies complicated by idiopathic oligohydramnios. The end goal is to help physicians use the best drug for their patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Pregnant women with gestational age between 26-37 weeks
  • Pregnant women whose age is < 35 years
  • Woman with other indication for elective caesarean section.
  • Women carrying a single fetus with no major anomalies.
  • Initial amniotic fluid index <8cm determined by reliable pelivabdominal ultrasound.

排除标准

  • Women complaining of other obstetric disorder such as, PPROM, preeclampsia, or diabetes.
  • Women with chronic illness such as, chronic hypertension, autoimmune disease or kidney disease.
  • Women who received other treatments for oligohydramnios in current pregnancy.
  • Women who smoke.
  • Fetuses with major congenital anomaly.

研究组 & 干预措施

sildn arm

Active Comparator

In this group, participants receive sildenafil 25 mg thrice a day. then amniotic fluid index is measured every week to measure its improvement. After delivery, APGAR will be measured. As well as, whether the fetus entered the NICU or not will be recorded.

干预措施: Sildenafil 25 MG (Drug)

L- argin arm

Active Comparator

In this group, participants receive L- arginine 1000 mg thrice a day. then amniotic fluid index is measured every week to measure its improvement. After delivery, APGAR will be measured. As well as, whether the fetus entered the NICU or not will be recorded.

干预措施: L-Arginine, 1000 Mg Oral Tablet (Drug)

结局指标

主要结局

Improvement of amniotic fluid index

时间窗: two hours before cesarean section

Amniotic fluid index level measured before delivery.

次要结局

  • NICU admission(first day after delivery)
  • APGAR score(5 minutes after delivery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ibtesam Teleb Mohamed Yousef Gadalla

principle investigator

Kafrelsheikh University

研究点 (2)

Loading locations...

相似试验